Emergency Filtration Products Receives FDA 510K Approval on Breathing Circuit Filter; Negotiations With Large Respiratory Care Product Distributor Underway.

Business Editors/Health & Medical Writers

LAS VEGAS--(BUSINESS WIRE)--March 5, 2002

Company Introduces Product to Veterans Administration and

Department of Defense

Emergency Filtration Products, Inc. (EFP) (OTCBB:EMFP) today announced the Federal Drug Administration (FDA) approval of a Class II medical device for its 2H Technology(TM) Breathing Circuit Filter (2H Filter). EFP's proprietary 2H Filter captures and isolates infectious pathogens by removing moisture and particulate from airflow at high levels of efficiency. The 2H Filter is compatible with numerous applications in ventilators, respirators and anesthesia circuits, and is EFP's first device in a planned series of high efficiency circuit filters targeting the worldwide hospital market.

FDA approval for the 2H Filter represents a pivotal and exciting development for the Company and its potential for growth. According to independent studies, the 2H Filter's target market is a $500 million medical disposable device market that comprises: respirators, ventilators, anesthesia circuit filters and emergency bag valve masks, among other applications. EFP is currently in negotiations with one of the world's largest respiratory care product distributors to have them market the 2H Filter to the general public, hospital and institutional health care market.

In addition, EFP has introduced the 2H Filter to the V.A. (Veterans Administration) and the Department of Defense. As part of its initial government marketing effort, EFP is in the process of obtaining its National Stocking number to make the 2H Filter available for all military medical applications.

About 2H Filter:

EFP's patented 2H Technology(TM) Breathing Circuit Filter combines hydrophilic (moisture absorbent) and hydrophobic (moisture repellent) filter media. Together, these materials create filter efficiencies of greater than 99.99 percent at a particle size of 0.027 microns according to independent laboratory tests.

About EFP:

EFP is an emergency medical product manufacturer which has developed products that are available to the market: the Vapor Isolation Valve(TM), RespAide(TM), a CPR mask used for resuscitation of respiratory/cardiac arrest cases, Superstat, a modified hemostatic collagen, an A.E.D. prep kit and the 2H inline Breathing Circuit Filter. EFP's RespAide and Superstat products are currently being sold to the Department of Defense and the General Services Administration.

Safe Harbor Statement: This news release contains forward-looking statements pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. With the exception of historical information, the matters discussed in this news release are "forward-looking statements" that involve a number of risks and uncertainties. The actual future results of the company could differ significantly from those statements.